| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 01/23/2003 | WO2002070685A3 Method of modifying the genome of gram-positive bacteria by means of a novel conditionally negative dominant marker gene |
| 01/23/2003 | WO2002070676A3 Use of protein histidine phosphatase |
| 01/23/2003 | WO2002050294A9 A novel tissue specific plant promoter |
| 01/23/2003 | WO2002050254A3 Crystal structure of glycogen synthase kinase 3 beta |
| 01/23/2003 | WO2002050066A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/23/2003 | WO2002048313A3 Senescence-associated plant promotors |
| 01/23/2003 | WO2002047466A3 Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof |
| 01/23/2003 | WO2002042435A3 Regulation of human tyrosine phosphatase |
| 01/23/2003 | WO2002040651A3 A human trna-specific adenosine deaminase |
| 01/23/2003 | WO2002036741A3 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 01/23/2003 | WO2002034921A3 FERMENTATIVE PRODUCTION OF D-p-HYDROXYPHENYLGLYCINE AND D-PHENYLGLYCINE |
| 01/23/2003 | WO2002033095A3 Regulation of human serine-threonine protein kinase |
| 01/23/2003 | WO2002031162A3 Regulation of human phospholipase a2-like enzyme |
| 01/23/2003 | WO2002029057A3 32144, a human fatty acid amide hydrolase and uses thereof |
| 01/23/2003 | WO2002026999A3 Regulation of human adam-ts-like protein |
| 01/23/2003 | WO2002026834A3 32624 a novel human udp-glucuronosyl and glycosyl transferase family member and uses thereof |
| 01/23/2003 | WO2002022794A3 ENDOTHELIN CONVERTING ENZYMES AND THE AMYLOID βPEPTIDE |
| 01/23/2003 | WO2002020796A3 Methanotrophic carbon metabolism pathway genes and enzymes |
| 01/23/2003 | WO2002018585A3 Packaging of positive-strand rna virus replicon particles |
| 01/23/2003 | WO2002018574A3 Human interleukin-four induced protein |
| 01/23/2003 | WO2002016601A3 Microorganisms and assays for the identification of antibiotics |
| 01/23/2003 | WO2002016583A3 Constructs and their use in metabolic pathway engineering |
| 01/23/2003 | WO2002010405A3 A human disintegrin protein |
| 01/23/2003 | WO2002010363A3 Protein phosphatases |
| 01/23/2003 | WO2002008415A1 METHOD OF SCREENING PTPz ACTIVITY PROMOTER OR INHIBITOR |
| 01/23/2003 | WO2002008397A3 A human atpase and uses therefor |
| 01/23/2003 | WO2002006330A3 13237,18480,2245 or 16228 human protein kinase molecules and uses therefor |
| 01/23/2003 | WO2002004022A9 High fidelity polymerases and uses thereof |
| 01/23/2003 | WO2001090365A3 Human protein kinase '13305' and uses therefor |
| 01/23/2003 | WO2001090337A3 Detection of rna |
| 01/23/2003 | WO2001090333A3 Recombinant bacterial phytases and uses thereof |
| 01/23/2003 | WO2001083782A3 Novel proteases |
| 01/23/2003 | WO2001079467A3 Identification of a renal nadph oxidase |
| 01/23/2003 | WO2001077311A3 Transcription factor stress-related proteins and methods of use in plants |
| 01/23/2003 | US20030018997 Nucleotide sequences for use in reducing nicotine concentration in tobacco |
| 01/23/2003 | US20030018985 Nucleotide sequences coding enzymatic polypeptide for use in the generation of preferential amino acid in plant seeds |
| 01/23/2003 | US20030018349 Nucleic acid molecules specific for bacterial antigens and uses thereof |
| 01/23/2003 | US20030018181 Antiinflammatory agents; culturing; isolation of fusion protein |
| 01/23/2003 | US20030018175 Sepsis shock therapy; anticoagulants; antiinflammatory agents |
| 01/23/2003 | US20030018168 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030018003 Rhob as a suppressor of cancer cell growth and cell transformation |
| 01/23/2003 | US20030017985 Molecules that influence pathogen resistance |
| 01/23/2003 | US20030017984 Binding to ligand; crystallization; cardiovascular disorders; Alzheimer's disease |
| 01/23/2003 | US20030017982 Genetic engineering; hybrid nucleic acids |
| 01/23/2003 | US20030017981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017969 Methods and pharmaceutical compositions for healing wounds |
| 01/23/2003 | US20030017965 Methods for treating certain diseases using naaladase inhibitors |
| 01/23/2003 | US20030017576 Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways |
| 01/23/2003 | US20030017575 Cell-wall degrading enzyme variants |
| 01/23/2003 | US20030017574 Peptide for use in human therapeutics and diagnostics |
| 01/23/2003 | US20030017573 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 01/23/2003 | US20030017572 Nucleotide sequences coding polypeptides for use in the treatment of cancer, arthritis alzheimer's and inflammatory diseases |
| 01/23/2003 | US20030017570 Chitinase materials and methods |
| 01/23/2003 | US20030017569 Nucleotide sequences coding polypeptide for use in the treatment of asthma and hematopoitic disorders |
| 01/23/2003 | US20030017568 Nucleotide sequences coding polypeptide for use in the treatment of muscle disorders |
| 01/23/2003 | US20030017567 Composition for use as analytical tool in polymerase chain reaction |
| 01/23/2003 | US20030017566 Polypeptide for use in prevention of parasitic infection in plants |
| 01/23/2003 | US20030017565 Composition for coating preferential surface and conveying strength, wear resistance, weatherability, rust-preventing properties, flame resistance, bactericidal, antiseptic and insect repelling properties |
| 01/23/2003 | US20030017564 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis |
| 01/23/2003 | US20030017563 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017557 Nucleotide sequences coding amino acid for use in human medicines and nutrient broths |
| 01/23/2003 | US20030017554 Fermentive generation of preferential amino acid; obtain microorganism, transform with vector, propagate, express vector, recover preferential amino acid |
| 01/23/2003 | US20030017551 Biological sample processing methods and compositions that include surfactants |
| 01/23/2003 | US20030017535 Nucleotide sequences coding polypeptide for use in the prevention and treatment of atherosclerosis, cardiovascular and cancerous disorders |
| 01/23/2003 | US20030017532 ndp |
| 01/23/2003 | US20030017520 High-efficiency assay for protein mannosyl transferases |
| 01/23/2003 | US20030017518 Detecting modulators of lipopolysaccharide phosphorylation; obtain test sample, incubate with antibody, monitor phosphorylation lipopolysaccharides |
| 01/23/2003 | US20030017512 Angiostatin receptor |
| 01/23/2003 | US20030017498 Nucleotide sequences coding polypeptides for use as tools in pharmacology, diagnostics, biosensors and bioreactors |
| 01/23/2003 | US20030017479 Methods for the detection, treatment, and prevention of neurodegeneration |
| 01/23/2003 | US20030017476 Nucleotide sequence coding polypeptide for use in the treatment and diagnosis of nervous system disorders |
| 01/23/2003 | US20030017473 Aspartoacylase gene, protein, and methods of screening for mutations associated with Canavan disease |
| 01/23/2003 | US20030017463 Nucleotide sequence coding polypeptide for use in the treatment of heart, cancer and skin disorders |
| 01/23/2003 | US20030017460 Compositions for enhanced catalyzed reporter deposition |
| 01/23/2003 | US20030017453 Method for screening restriction endonucleases |
| 01/23/2003 | US20030017218 Soft tissue anticancer agents |
| 01/23/2003 | US20030017215 Soft tissue anticancer agents |
| 01/23/2003 | US20030017160 Human checkpoint kinase, hCDS1, compositions and methods |
| 01/23/2003 | US20030017144 Lipase-containing composition and methods of use thereof |
| 01/23/2003 | CA2453672A1 Root nodule bacteria having enhanced nitrogen-fixation ability |
| 01/23/2003 | CA2453566A1 Method and composition for inhibiting heparanase activity |
| 01/23/2003 | CA2453406A1 Methods for reducing immunogenicity of polypeptides |
| 01/23/2003 | CA2453285A1 Use of cross-linked, covalently bound urokinase plasminogen activator (scupa)-urokinase plasminogen activator receptor (supar) complex as a fibrinolytic agent |
| 01/23/2003 | CA2453136A1 Replikin peptides and uses thereof |
| 01/23/2003 | CA2452476A1 Mediating the effects of alcohol consumption by orally administering active dry yeast |
| 01/23/2003 | CA2451569A1 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases |
| 01/23/2003 | CA2450721A1 Method of elevating glutamic acid content in plant and plants having elevated glutamic acid content |
| 01/23/2003 | CA2449243A1 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/23/2003 | CA2448517A1 Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses |
| 01/22/2003 | EP1277839A1 L-glutamate oxidase |
| 01/22/2003 | EP1277838A1 Recombinant anti-tumor RNASE |
| 01/22/2003 | EP1277834A1 Glucuronofucan sulfate |
| 01/22/2003 | EP1277833A2 Costal-2 homologue |
| 01/22/2003 | EP1277832A1 Polynucleotides encoding insect ethanolamine kinase and uses therefor |
| 01/22/2003 | EP1277762A2 Low allergenic protein variants |
| 01/22/2003 | EP1277476A1 Utilization of adamts-1 protein and method of screening aggrecanase activity regulator |
| 01/22/2003 | EP1277464A2 Liposome coated with polyhydroxyalkanoate and production method thereof |
| 01/22/2003 | EP1276902A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 01/22/2003 | EP1276897A2 Live cell procedures to identify compounds modulating intracellular distribution of phosphodiesterase (pde) enzymes |
| 01/22/2003 | EP1276883A2 Amino acid:glyoxylate aminotransferase genes from plants and uses thereof |